Cargando…
The role of chemotherapy in the management of olfactory neuroblastoma: A 40‐year surveillance, epidemiology, and end results registry study
BACKGROUND: In this retrospective surveillance, epidemiology, and end results (SEER) registry analysis, we investigated the role of chemotherapy (CT) in the treatment of olfactory neuroblastoma (ON), an exceedingly rare sino‐nasal tumor typically treated with surgery and/or radiation therapy (RT). M...
Autores principales: | Brisson, Ryan J., Quinn, Thomas J., Deraniyagala, Rohan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088587/ https://www.ncbi.nlm.nih.gov/pubmed/33969231 http://dx.doi.org/10.1002/hsr2.257 |
Ejemplares similares
-
The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program
por: Healy, Mark A., et al.
Publicado: (2018) -
Area-Level Attributes and Esophageal Adenocarcinoma in Surveillance, Epidemiology and End Results Registries
por: Ghazarian, Armen A., et al.
Publicado: (2013) -
Validation of prostate‐specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries
por: Adamo, Margaret (Peggy), et al.
Publicado: (2016) -
Facial disfigurement due to olfactory neuroblastoma: beauty regained with chemotherapy
por: Kumar, Parmod, et al.
Publicado: (2020) -
Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry
por: Lu, Tzu-Pin, et al.
Publicado: (2021)